BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands 
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions 
Winter Storm Disrupts Northeast Travel as Snow and Ice Blanket New York, New Jersey 
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge 
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue 
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio 
Nvidia and Groq Strike Strategic AI Inference Licensing Deal 
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025 
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling 
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock 
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance 
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions 
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio 
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards 
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns 
California DMV Proposes New Safety Rules for Autonomous Vehicles After Waymo Incidents 
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares 
WALTHAM, Mass., Feb. 29, 2016 -- Radius Health, Inc. (Nasdaq:RDUS), a science-driven biopharmaceutical company focused on developing new therapeutics for patients with osteoporosis, hormone responsive metastatic breast cancer, and other postmenopausal conditions including vasomotor symptoms announced that President and Chief Executive Officer, Robert E. Ward, will present at the Cowen and Company 36th Annual Health Care Conference on March 8, 2016 at 8:40 a.m. ET at the Boston Marriott Copley Place, Boston, Mass.
The Company’s presentation will be webcast live on the Company's website at www.radiuspharm.com, and a replay of the presentation will be available on the Company’s website following the presentation. The Company will post a copy of the presentation materials on its website, www.radiuspharm.com, prior to the start of the presentation.
Investor Relations Barbara Ryan Email: [email protected] Phone: 203-274-2825 Media Contact: Lori Gorski Email: [email protected] Phone: 617-551-4096
